Usal A, Acartürk E, Yüregir G T, Unlükurt I, Demirci C, Kurt H I, Birand A
Department of Cardiology, Medical Faculty, Cukurova University, Adana, Turkey.
Jpn Heart J. 1996 Mar;37(2):177-82. doi: 10.1536/ihj.37.177.
Although experimental studies have demonstrated that reduced glutathione (GSH) is involved in cellular protection from deleterious effects of oxygen free radicals (OFRs) in ischemia and reperfusion, there are controversial data on the correlation between the levels of erythrocyte GSH and the ischemic process. To clarify, we determined the erythrocyte GSH levels in 21 patients with acute myocardial infarction (AMI), aged 39-70, who were not given thrombolytic therapy and 21 age- and sex- matched healthy controls. Samples of blood were taken on days 1, 3, 5 and 7 from AMI patients and on the same days from the controls. The GSH levels of patients with AMI were significantly depressed by 11.5% as compared to the controls on the second day after infarction (7.44 +/- 1.71 vs 8.41 +/- 1.54 U/gHb p < 0.05). Although the total mean of GSH levels for all days was lower (3.8%) in patients than in the controls, this finding did not reach statistical significance (7.41 +/- 1.71 vs 7.71 +/- 1.27 U/gHb, ns). There was no correlation between the erythrocyte GSH levels and cardiac enzyme concentrations, infarct localization, hemodynamic status according to Killip classification and the frequency of ventricular arrhythmias. This preliminary work suggests that depressed GSH levels may be associated with an enhanced protective mechanism to oxidative stress in AMI. Measurements of erythrocyte GSH can be helpful in the estimation of oxidative stress in the course of AMI. However, further research must be done to determine the primary scavenger in AMI by analyzing all the enzymes and substrates involved in the endogeneous system that controls the effects of OFRs.
尽管实验研究表明,还原型谷胱甘肽(GSH)参与细胞保护,使其免受缺血再灌注过程中氧自由基(OFRs)的有害影响,但关于红细胞GSH水平与缺血过程之间的相关性,仍存在有争议的数据。为了阐明这一点,我们测定了21例年龄在39 - 70岁之间、未接受溶栓治疗的急性心肌梗死(AMI)患者以及21例年龄和性别匹配的健康对照者的红细胞GSH水平。在第1、3、5和7天采集AMI患者的血样,并在相同日期采集对照者的血样。与对照组相比,AMI患者在梗死发生后第二天的GSH水平显著降低了11.5%(7.44±1.71 vs 8.41±1.54 U/gHb,p<0.05)。尽管患者GSH水平的总均值在所有天数均低于对照组(3.8%),但这一发现未达到统计学显著性(7.41±1.71 vs 7.71±1.27 U/gHb,无显著性差异)。红细胞GSH水平与心肌酶浓度、梗死部位、根据Killip分级的血流动力学状态以及室性心律失常的发生率之间均无相关性。这项初步研究表明,GSH水平降低可能与AMI中氧化应激的增强保护机制有关。测定红细胞GSH有助于评估AMI过程中的氧化应激。然而,必须通过分析内源性系统中所有参与控制OFRs作用的酶和底物,进一步开展研究以确定AMI中的主要清除剂。